medigraphic.com
ISSN 1665-2576 (Impreso)

2009, Número 1

<< Anterior Siguiente >>

Rev Mex Cir Endoscop 2009; 10 (1)


Aplicaciones de NOTES en cirugía bariátrica

Escalona A

Idioma: Español
Referencias bibliográficas: 33
Paginas: 27-32
Archivo PDF: 214.93 Kb.


RESUMEN

La cirugía endoscópica transluminal a través de orificios naturales (NOTESTM, Natural Orifice Translumenal Endoscopic Surgery) junto a la cirugía endoluminal son dos nuevas áreas del desarrollo de la cirugía mínimamente invasiva. Existen numerosos artículos que describen distintas aplicaciones en el tratamiento de la obesidad de estos accesos en modelos animal y humano. Corresponden a experiencias iniciales donde se evalúa principalmente la factibilidad de estos procedimientos. En este artículo se revisará la experiencia que existe actualmente en el tratamiento endoscópico transluminal (NOTESTM) y endoluminal en el tratamiento de la obesidad en pacientes, como también su desarrollo en modelos de trabajo animal. Se revisarán los distintos objetivos de este tipo de procedimientos así como los mecanismos de acción.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rattner D, Kalloo A. ASGE/SAGES Working Group on Natural Orifice Transluminal Endoscopic Surgery. October 2005. Surg Endosc 2006; 20: 329-333.

  2. Kalloo AN, Singh VK, Jagannath SB, et al. Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity. Gastrointest Endosc 2004; 60: 114-117.

  3. Marescaux J, Dallemagne B, Perretta S, Wattiez A, Mutter D, Coumaros D. Surgery Without Scars: Report of transluminal cholecystectomy in a human being. Arch Surg 2007; 142: 823-826.

  4. Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc 2007; 21: 347-356.

  5. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1: 198-199.

  6. Melissas J, Mouzas J, Filis D et al. The intragastric balloon - smoothing the path to bariatric surgery. Obes Surg 2006; 16: 897-902.

  7. Mion F, Gincul R, Roman S et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg 2007;17:764-769.

  8. Forestieri P, De Palma GD, Formato A et al. Heliosphere Bag in the treatment of severe obesity: preliminary experience. Obes Surg 2006; 16: 635-637.

  9. Dumonceau JM. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-1617.

  10. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61: 19-27.

  11. Rubino F, Forgione A, Cummings DE et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749.

  12. Laferrere B, Teixeira J, McGinty J et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.

  13. Milone L, Gagner M, Ueda K, Bardaro SJ, Ki-Young Y. Effect of a polyethylene endoluminal duodeno-jejunal tube (EDJT) on weight gain: a feasibility study in a porcine model. Obes Surg 2006; 16: 620-626.

  14. Rodríguez-Grunert L, Galvao Neto MP, Álamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-59.

  15. Gersin KS, Keller JE, Stefanidis D et al. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007; 14: 275-278.

  16. Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195-197.

  17. Deitel M, Crosby RD, Gagner M. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg 2008; 18: 487-496.

  18. Mechanick JI, Kushner RF, Sugerman HJ et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008; 4: S109-84.

  19. Mintz Y, Horgan S, Savu MK et al. Hybrid natural orifice transluminal surgery (NOTES) sleeve gastrectomy: a feasibility study using an animal model. Surg Endosc 2008; 22: 1798-802.

  20. Ramos AC, Zundel N, Neto MG, Maalouf M. Human hybrid NOTES transvaginal sleeve gastrectomy: initial experience. Surg Obes Relat Dis 2008; 4: 660-663.

  21. Johnston D, Dachtler J, Sue-Ling HM, King RF, Martin G. The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003; 13: 10-16.

  22. Deviere J, Ojeda Valdés G, Cuevas Herrera L et al. Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surg Endosc 2008; 22: 589-598.

  23. Moreno C, Closset J, Dugardeyn S et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40: 406-413.

  24. Cigaina V. Long-term follow-up of gastric stimulation for obesity: the Mestre 8-year experience. Obes Surg 2004; 14 Suppl 1: S14-22.

  25. Camilleri M, Toouli J, Herrera MF et al. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis 2008.

  26. Chen J. Mechanisms of action of the implantable gastric stimulator for obesity. Obes Surg 2004; 14 Suppl 1: S28-32.

  27. Sallam HS, Chen JD, Pasricha PJ. Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc 2008; 68: 754-759.

  28. Aly A. Argon plasma coagulation and gastric bypass-a novel solution to stomal dilation. Obes Surg 2008.

  29. Spaulding L, Osler T, Patlak J. Long-term results of sclerotherapy for dilated gastrojejunostomy after gastric bypass. Surg Obes Relat Dis 2007; 3: 623-626.

  30. Schweitzer M. Endoscopic intraluminal suture plication of the gastric pouch and stoma in postoperative Roux-in-Y gastric bypass patients. J Laparoendosc Adv Surg Tech A 2004; 14: 223-226.

  31. Thompson CC, Slattery J, Bundga ME, Lautz DB. Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-in-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc 2006; 20: 1744-1748.

  32. Christou NV, Sampalis JS, Liberman M et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-23; discussion 23-24.

  33. Nguyen NT, Goldman C, Rosenquist CJ et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001; 234: 279-89; discussion 89-91.




2020     |     www.medigraphic.com